avelumab,atezolizumab,Docetaxel,Paclitaxel,Vinflunine
roche,merck,pfizer
['avelumab', 'atezo', 'imvigor130', '#gu,(-#gui),(-#gunagratinib),(-#guard),(-#gut)', 'imvigor,11', 'biomarker', ' uc,(-ucsd),(-ucsf),', 'marker ']
a takeover of for onclive imvigor130:atezo vs chemo final os results in 1st line uc atezo was not tested due to trial design. the data looks good but exploratory. why would this 142 biomarker works here and not elsewhere (im211 im010) #gu23 avelumab is still soc imo. 
Healthcare publisher of oncology focused articles, videos, panel discussions, and much more that run the gamut of oncology care and management.